Insider · CIK 0001749836
Oliver J. Spandow
Files at NEPH (NEPHROS INC). First filing -, latest -.
Oliver J. Spandow files SEC Form 4 as director at NEPH (NEPHROS INC). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Oliver J. Spandow has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 10, 2025 | NEPH NEPHROS INC | AGrant or award Common Stock | +8,036 | $0.00 | $0 | 122,881 | Nov 13, 2025 |
Questions about Oliver J. Spandow
Answered from the filings on this page, as of the latest one.
Is Oliver J. Spandow buying or selling?
Oliver J. Spandow has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Oliver J. Spandow's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Oliver J. Spandow has 0.
Where does Oliver J. Spandow file Form 4?
Oliver J. Spandow has filed Form 4 at NEPH (NEPHROS INC). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.